Does ACLARUBICIN Cause Off label use? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Off label use have been filed in association with ACLARUBICIN. This represents 12.1% of all adverse event reports for ACLARUBICIN.
38
Reports of Off label use with ACLARUBICIN
12.1%
of all ACLARUBICIN reports
6
Deaths
4
Hospitalizations
How Dangerous Is Off label use From ACLARUBICIN?
Of the 38 reports, 6 (15.8%) resulted in death, 4 (10.5%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACLARUBICIN. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does ACLARUBICIN Cause?
Myelosuppression (80)
Bone marrow failure (73)
Nausea (35)
Infection (26)
Acute myeloid leukaemia (24)
Product use in unapproved indication (22)
Platelet count decreased (21)
Febrile neutropenia (19)
Pneumonia (19)
Thrombocytopenia (18)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ACLARUBICIN Alternatives Have Lower Off label use Risk?
ACLARUBICIN vs ACLIDINIUM
ACLARUBICIN vs ACLIDINIUM\FORMOTEROL
ACLARUBICIN vs ACORAMIDIS
ACLARUBICIN vs ACTEMRA
ACLARUBICIN vs ACTIQ